TENAX THERAPEUTICS, INC.: 10-Q filed 2011-09-19
What TENAX THERAPEUTICS, INC. reported in its quarterly report filed 2011-09-19 (fiscal Q1 2012): 33 published measures, 83 facts as tagged in accession 0001354488-11-003481.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2011-09-19
- Fiscal period
- fiscal Q1 2012
- Accession
- 0001354488-11-003481 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All TENAX THERAPEUTICS, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-07-31 | 6,175,578 | USD | |
| At 2011-04-30 | 2,922,356 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-07-31 | 7,793,584 | USD | |
| At 2011-04-30 | 6,646,879 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-07-31 | -1,618,006 | USD | |
| At 2011-04-30 | -3,724,523 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-07-31 | 3,998,147 | USD | |
| At 2011-04-30 | 951,944 | USD | |
| At 2010-07-31 | 2,731,665 | USD | |
| At 2010-04-30 | 632,706 | USD | |
| At 1967-05-25 | 0 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-05-01 to 2011-07-31 | 2,869,308 | USD | 92 |
| 1967-05-26 to 2011-07-31 | 94,785,182 | USD | 16138 |
| 2010-05-01 to 2010-07-31 | 3,002,300 | USD | 92 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-05-01 to 2011-07-31 | -2,053,805 | USD | 92 |
| 1967-05-26 to 2011-07-31 | -46,075,991 | USD | 16138 |
| 2010-05-01 to 2010-07-31 | -2,613,415 | USD | 92 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-05-01 to 2011-07-31 | 0 | USD | 92 |
| 1967-05-26 to 2011-07-31 | -1,744,091 | USD | 16138 |
| 2010-05-01 to 2010-07-31 | -88,906 | USD | 92 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-05-01 to 2011-07-31 | 5,186,692 | USD | 92 |
| 1967-05-26 to 2011-07-31 | 53,419,252 | USD | 16138 |
| 2010-05-01 to 2010-07-31 | 4,871,495 | USD | 92 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-05-01 to 2011-07-31 | -86,684 | USD | 92 |
| 1967-05-26 to 2011-07-31 | -3,345,114 | USD | 16138 |
| 2010-05-01 to 2010-07-31 | -159,121 | USD | 92 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-07-31 | -94,785,182 | USD | |
| At 2011-04-30 | -91,915,874 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-05-01 to 2011-07-31 | 23,395,565 | shares | 92 |
| 2010-05-01 to 2010-07-31 | 23,215,708 | shares | 92 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-05-01 to 2011-07-31 | 24,143,997 | shares | 92 |
| 2010-05-01 to 2010-07-31 | 23,215,708 | shares | 92 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-05-01 to 2011-07-31 | -0.12 | USD/shares | 92 |
| 2010-05-01 to 2010-07-31 | -0.13 | USD/shares | 92 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-05-01 to 2011-07-31 | -0.33 | USD/shares | 92 |
| 2010-05-01 to 2010-07-31 | -0.13 | USD/shares | 92 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-07-31 | 392,116 | USD | |
| At 2011-04-30 | 442,586 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-05-01 to 2011-07-31 | 25,236 | USD | 92 |
| 1967-05-26 to 2011-07-31 | 580,237 | USD | 16138 |
| 2010-05-01 to 2010-07-31 | 48,795 | USD | 92 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-05-01 to 2011-07-31 | 2,428,077 | USD | 92 |
| 1967-05-26 to 2011-07-31 | 63,080,649 | USD | 16138 |
| 2010-05-01 to 2010-07-31 | 3,023,201 | USD | 92 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-07-31 | 4,500,796 | USD | |
| At 2011-04-30 | 1,632,211 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-05-01 to 2011-07-31 | 435,798 | USD | 92 |
| 1967-05-26 to 2011-07-31 | 32,747,307 | USD | 16138 |
| 2010-05-01 to 2010-07-31 | 1,206 | USD | 92 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-07-31 | 2,266,593 | USD | |
| At 2011-04-30 | 2,183,244 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-07-31 | 1,058,604 | USD | |
| At 2011-04-30 | 889,376 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-07-31 | 28,119 | USD | |
| At 2011-04-30 | 138,867 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-05-01 to 2011-07-31 | 2,452,950 | USD | 92 |
| 1967-05-26 to 2011-07-31 | 63,217,042 | USD | 16138 |
| 2010-05-01 to 2010-07-31 | 3,028,311 | USD | 92 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-07-31 | 205,486 | USD | |
| At 2011-04-30 | 257,382 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-05-01 to 2011-07-31 | 24,873 | USD | 92 |
| 1967-05-26 to 2011-07-31 | 136,393 | USD | 16138 |
| 2010-05-01 to 2010-07-31 | 5,110 | USD | 92 |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-05-01 to 2011-07-31 | 1,800,989 | USD | 92 |
| 1967-05-26 to 2011-07-31 | 42,618,250 | USD | 16138 |
| 2010-05-01 to 2010-07-31 | 1,883,068 | USD | 92 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-05-01 to 2011-07-31 | 651,961 | USD | 92 |
| 1967-05-26 to 2011-07-31 | 20,264,635 | USD | 16138 |
| 2010-05-01 to 2010-07-31 | 1,145,243 | USD | 92 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-07-31 | 23,400,085 | shares | |
| At 2011-04-30 | 23,393,307 | shares |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-07-31 | 746,033 | USD | |
| At 2011-04-30 | 699,951 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-07-31 | 161,512 | USD | |
| At 2011-04-30 | 147,608 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-07-31 | 1,191,690 | USD | |
| At 2011-04-30 | 1,250,573 | USD |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-05-01 to 2011-07-31 | 5,433 | USD | 92 |
| 1967-05-26 to 2011-07-31 | -1,292,871 | USD | 16138 |
| 2010-05-01 to 2010-07-31 | -22,107 | USD | 92 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-05-01 to 2011-07-31 | 22,398 | USD | 92 |
| 1967-05-26 to 2011-07-31 | 260,424 | USD | 16138 |
| 2010-05-01 to 2010-07-31 | 97,936 | USD | 92 |
Inspect the source
- Entity
- TENAX THERAPEUTICS, INC. / CIK 0000034956
- Captured
- 2026-09-19T14:46:45.117Z
- SEC response SHA-256
3f4f90f5f823d316ffb20bc63506ae090888657f5ff1cb9568439e153f028cf5
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000034956.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))